热门资讯> 正文
Teva任命Serge Rogasik为CDMO业务API的首席执行官
2026-10-01 05:26
- Teva Pharmaceutical Industries appointed Serge Rogasik as CEO of TAPI (Technology & API Services), its active pharmaceutical ingredients and contract development and manufacturing organization division.
- Rogasik was most recently CEO of Kensing, a specialty ingredients company. He has also worked at Vantage Specialty Chemicals, Addivant, BASF, and Eastman Chemical Company.
- TAPI has ~4100 employees and 12 sites globally.
More on Teva Pharmaceutical Industries
- Teva Pharmaceutical Industries Limited (TEVA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
- Teva Pharmaceutical Industries Limited (TEVA) Presents at U.S. All Stars Conference Transcript
- Teva Pharmaceutical Industries Limited (TEVA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- Teva wins biosimilar approval of Amgen's Xgeva
- Trump seeks to produce more generic drugs in the US
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。